4.4 Article

Vogt-Koyanagi-Harada-like Syndrome After CTLA-4 Inhibition With Ipilimumab for Metastatic Melanoma

Journal

JOURNAL OF IMMUNOTHERAPY
Volume 38, Issue 2, Pages 80-84

Publisher

Ovid Technologies (Wolters Kluwer Health)
DOI: 10.1097/cji.0000000000000066

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available